SCHEMBL3658838

SCHEMBL3658838

O=C(O)c1cc(-c2nnn[nH]2)cc(-c2ccc(Cl)cc2F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.41
ALPL P05186 2/20 0.37
EIF4E P06730 1/20 0.37
MARS1 P56192 1/20 0.37
SRD5A2 P31213 2/20 0.36
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
MAP2K4 P45985 1/20 0.36
AURKA O14965 1/20 0.36
TPX2 Q9ULW0 1/20 0.36
APP P05067 1/20 0.36
GRM2 Q14416 1/20 0.36
AKR1C1 Q04828 1/20 0.35
FASN P49327 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRB3 P13945 1/20 0.35
SRD5A1 P18405 1/20 0.35
DHODH Q02127 1/20 0.34
KDM5A P29375 1/20 0.34
KDM5B Q9UGL1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3655049 0.88 TTR (0.42) KMOALPLAKR1C3AKR1C2MAP2K4
SCHEMBL3653446 0.88 MARS1 (0.49) ALPLMARS1SRD5A2MAP2K4AURKA
SCHEMBL3663117 0.86 JAK2 (0.43) ALPLAKR1C3AKR1C2MAP2K4GRM2
SCHEMBL3650607 0.85 ALDH1A1 (0.39) ALPLEIF4EMARS1SRD5A2MAP2K4
SCHEMBL3655915 0.84 MAOA (0.43) DHODHKDM5AKDM5B
SCHEMBL3660881 0.83 AXL (0.38) ALPLEIF4EMARS1SRD5A2MAP2K4
SCHEMBL3652199 0.82 CTRC (0.47) ALPLMAP2K4AURKATPX2DHODH
SCHEMBL3652824 0.81 ALDH1A1 (0.44)
SCHEMBL3650933 0.80 DHODH (0.40) KMOEIF4EMAP2K4DHODH
SCHEMBL3655999 0.79 ALPL (0.46) KMOALPLKDM5AKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234989-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2010-10-06 EP disclosed
WO-2009077371-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND/OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-06-25 WO disclosed
EP-2038264-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000645-A1 TETRAZOLE-SUBSTITUTED ARYLAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed